• This email address is being protected from spambots. You need JavaScript enabled to view it.

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Ahmed, K., Baeten, J.M., Beksinska, M., Bekker, L.G., Bukusi, E.A., Donnell, D., Gichangi, P.B., Heller, K.B., Hofmeyr, G.J., Justman, J. and Kasaro, M.P., 2019. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. The Lancet, 394(10195), pp.303-313.


© 2024 The Aurum Institute. All Rights Reserved.